Diabetic Retinopathy News and Research

RSS
In the initial stages, people with diabetic retinopathy may not notice their vision changing. Diabetics sometimes experience rapid changes in blood sugar that can temporarily cause blurry vision even when retinopathy is not present. If a person notices a few specks or spots floating in his visual field, this may mean he has developed proliferative diabetic retinopathy, the growth of abnormal new blood vessels on the retina and optic nerve. High blood sugar levels have been linked in studies to retinal blood vessel abnormalities. Blurred vision may occur when the macula--the small area at the center of the retina--swells as it fills with fluid that has leaked from retinal blood vessels. Because damage to the eye often develops slowly, early detection of diabetes and control of blood sugar through diet and medications can make a crucial difference in saving vision.

Effective diabetic retinopathy treatments include laser photocoagulation for early to moderate stages and a microsurgery called vitrectomy for repair of eyes with extensive damage. Injectable and oral medications that act on abnormal blood vessels to control diabetic retinopathy before vision loss occurs are now in development. Early detection would be key to the effectiveness of these treatments, also.
Microglia play  protective role in response to retinal detachment, shows study

Microglia play protective role in response to retinal detachment, shows study

People with type 1 diabetes for decades show signs of mild drop in cognitive abilities

People with type 1 diabetes for decades show signs of mild drop in cognitive abilities

Limited health literacy blocks heart disease prevention and treatment

Limited health literacy blocks heart disease prevention and treatment

Unique imaging technique identifies biomarkers of cellular damage done by diabetic retinopathy

Unique imaging technique identifies biomarkers of cellular damage done by diabetic retinopathy

PanOptica doses first patient in Phase 1/2 dose-ranging clinical trial of PAN-90806

PanOptica doses first patient in Phase 1/2 dose-ranging clinical trial of PAN-90806

Siemens Healthineers and Hill-Rom join to provide comprehensive solutions for primary diabetes care

Siemens Healthineers and Hill-Rom join to provide comprehensive solutions for primary diabetes care

MU researchers use new techniques to fight against diabetic retinopathy

MU researchers use new techniques to fight against diabetic retinopathy

FDA approves marketing of AI device to detect diabetic retinopathy

FDA approves marketing of AI device to detect diabetic retinopathy

FDA authorizes marketing of first AI device to detect diabetic retinopathy

FDA authorizes marketing of first AI device to detect diabetic retinopathy

Unexpected finding may play major role in deterring diabetic retinopathy

Unexpected finding may play major role in deterring diabetic retinopathy

Researchers find expression of lymphatic markers in proliferative diabetic retinopathy tissues

Researchers find expression of lymphatic markers in proliferative diabetic retinopathy tissues

Robocall increases diabetic retinopathy screening rates among poor minorities

Robocall increases diabetic retinopathy screening rates among poor minorities

Researchers build better AI algorithms to screen patients for diabetic eye disease

Researchers build better AI algorithms to screen patients for diabetic eye disease

Protein pathways linked to heart disease, diabetic complications identified in patients with diabetes

Protein pathways linked to heart disease, diabetic complications identified in patients with diabetes

The training of Dr. Robot: Data wave hits medical care

The training of Dr. Robot: Data wave hits medical care

New projects to develop innovative technologies to address global health challenges

New projects to develop innovative technologies to address global health challenges

Study finds close connection between eye and cardiovascular damage in type 1 diabetes

Study finds close connection between eye and cardiovascular damage in type 1 diabetes

Targeted interventions can increase screening for diabetic retinopathy, study shows

Targeted interventions can increase screening for diabetic retinopathy, study shows

New organ-on-a-chip technology provides simple setting to study blood vessel formation

New organ-on-a-chip technology provides simple setting to study blood vessel formation

JAX researcher receives grant for retinal disease research

JAX researcher receives grant for retinal disease research

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.